ENTEROSTATIN (PIG, RAT) manufacturers
|
| | ENTEROSTATIN (PIG, RAT) Basic information |
| Product Name: | ENTEROSTATIN (PIG, RAT) | | Synonyms: | H-VAL-PRO-ASP-PRO-ARG-OH;ENTEROSTATIN (PIG, RAT);ENTEROSTATIN, PORCINE, RAT;V-P-D-P-R;L-Arginine, L-valyl-L-prolyl-L-α-aspartyl-L-prolyl-;Enterostatin(rat);ENTEROSTATIN (PIG, RAT) USP/EP/BP;VAL-PRO-ASP-PRO-ARG | | CAS: | 117137-85-6 | | MF: | C25H42N8O8 | | MW: | 582.65 | | EINECS: | | | Product Categories: | Peptide;Various Peptides | | Mol File: | 117137-85-6.mol |  |
| | ENTEROSTATIN (PIG, RAT) Chemical Properties |
| density | 1.53±0.1 g/cm3(Predicted) | | storage temp. | -15°C | | pka | 3.60±0.21(Predicted) |
| | ENTEROSTATIN (PIG, RAT) Usage And Synthesis |
| Uses | Enterostatin (rat), an orally active activation peptide of procolipase, selectively reduces fat intake. Enterostatin (rat) reduces serum cholesterol levels by way of a CCK1 receptor-dependent mechanism[1][2]. | | in vivo | Enterostatin (rat) (50-100 mg/kg; p.o.) has a hypocholesterolemic effect mediated by CCK1 receptor in male ddY mice[1]. | Animal Model: | Male ddY mice[1] | | Dosage: | 50 and 100 mg/kg | | Administration: | Oral administration | | Result: | Reduced serum cholesterol levels after oral administration at a dose of 100 mg/kg. |
| | References | [1] Takenaka Y, et, al. Enterostatin reduces serum cholesterol levels by way of a CCK(1) receptor-dependent mechanism. Peptides. 2008 Dec;29(12):2175-8. DOI:10.1016/j.peptides.2008.08.021
[2] Erlanson-Albertsson C, et, al. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiol Behav. 1991 Jun;49(6):1191-4. DOI:10.1016/0031-9384(91)90350-w |
| | ENTEROSTATIN (PIG, RAT) Preparation Products And Raw materials |
|